J&J Enters LAA Closure Market In Earnest With Coherex Buy
This article was originally published in The Gray Sheet
Executive Summary
J&J's Biosense Webster heart-rhythm device unit has acquired privately held partner Coherex Medical, solidifying its stake in the left atrial appendage closure market that Boston Scientific currently leads.